Inhibition of fatty acid oxidation by 2-bromooctanoate. Including effects of bromooctanoate on ketogenesis and gluconeogenesis.
D000214:Acyl Coenzyme A / Q000378:metabolism; D000818:Animals; D002210:Caprylates / Q000494:pharmacology*; D003065:Coenzyme A / Q000378:metabolism; D005227:Fatty Acids / Q000378:metabolism*; D005943:Gluconeogenesis / Q000187:drug effects*; D007657:Ketone Bodies / Q000096:biosynthesis*; D007700:Kinetics; D008099:Liver / Q000187:drug effects / Q000378:metabolism*; D008297:Male; D008930:Mitochondria, Liver / Q000187:drug effects / Q000378:metabolism; D010084:Oxidation-Reduction; D010101:Oxygen Consumption / Q000187:drug effects; D010477:Perfusion; D051381:Rats
D000214:Acyl Coenzyme A; D002210:Caprylates; D005227:Fatty Acids; D007657:Ketone Bodies; C019279:2-bromooctanoic acid; D003065:Coenzyme A